An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
Conditions: Prevention of Venous Thromboembolism; Congenital Heart Disease; Fontan Procedure; Children Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939) Sponsors: Bayer; Janssen Research& Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Child Development | Children | Heart | Heart Disease | Learning | Research | Study | Thrombosis | Universities & Medical Training